510(k) K193028

MEDRAD Mark 7 Arterion Injection System by Bayer Medical Care, Inc. — Product Code DXT

K193028 is an FDA 510(k) premarket notification submitted by Bayer Medical Care, Inc. for the device "MEDRAD Mark 7 Arterion Injection System". The FDA issued a decision of Substantially Equivalent on December 5, 2019. The device falls under product code DXT (Injector And Syringe, Angiographic), a Class II device regulated under 21 CFR 870.1650. Bayer Medical Care, Inc. has at least 9 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
December 5, 2019
Date Received
October 30, 2019
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Injector And Syringe, Angiographic
Device Class
Class II
Regulation Number
870.1650
Review Panel
HO
Submission Type